Updated Jul 16, 2026
Czibere Akos has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.39M.

Akos Czibere (family name Czibere, given name Akos; sometimes listed as Czibere Akos) is a corporate executive affiliated with Aktis Oncology, Inc. Public SEC filings as of 2026-07-10 show him in connection with Aktis Oncology, though specific title details are not provided in the available context. There is limited publicly available biographical information beyond his association with Aktis Oncology, and he does not appear to be a widely publicized figure outside this context.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-10 | AKTS | Aktis Oncology, Inc. | S — Open-market sale | 4.4K | $28.71 | $125K |
| 2026-07-10 | AKTS | Aktis Oncology, Inc. | S — Open-market sale | 30.8K | $27.95 | $862K |
| 2026-07-10 | AKTS | Aktis Oncology, Inc. | S — Open-market sale | 14.8K | $27.13 | $401K |
| 2026-07-10 | AKTS | Aktis Oncology, Inc. | M — Option exercise | 50.0K | $4.95 | $248K |
Akos Czibere (family name Czibere, given name Akos; sometimes listed as Czibere Akos) is a corporate executive affiliated with Aktis Oncology, Inc. Public SEC filings as of 2026-07-10 show him in connection with Aktis Oncology, though specific title details are not provided in the available context. There is limited publicly available biographical information beyond his associa…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($1.39M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Czibere Akos profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.